September 15, 2023 By Grant Miller, OD My goal with myopia management is to provide an experience. I’ve created the Myopia Management...
SAN DIEGO — Sydnexis Inc., a clinical stage biopharmaceutical company focused on the treatment of progressive myopia in children and minimizing the...
sponsored content August 15, 2023 By Kristen Dalli, Managing Editor, Review of Myopia Management ‘Pediatric ophthalmologists are the tip of the spear....
August 15, 2023 By Nayiri Ajoian, OD The success of myopia management has a lot to do with the fact that my...
sponsored content August 15, 2023 Myopia is the most common eye disease in children and has experienced a dramatic increase in prevalence...
August 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Eye care professionals frequently prescribe topical low-dose atropine to slow myopic...
August 1, 2023 By Craig Woods, BSc (Hons), PhD, MCOptom, Clinical Consultant, BHVI Can we start the conversation with our patients/parents about...
July 17, 2023 By Dwight Barnes, OD, FIAOMC, IACMM It is essential to schedule some more time for that initial evaluation to...
July 5, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Most published myopia clinical trials study a single intervention versus control,...
July 5, 2023 By Vishakha Thakrar, OD, FAAO, FSLS Many practitioners will implement every myopia management strategy available, and others will choose...
June 15, 2023 By Laura Vasilakos, OD, FCOVD Much like primary care providers measure blood pressure as a risk factor for disease,...
June 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In a new study recently published in JAMA Ophthalmology, a novel preservative-free...
June 6, 2023 BRIDGEWATER, N.J. — The U.S. Food and Drug Administration (FDA) has accepted Vyluma’s new drug application (NDA) for its...
May 22, 2023 ROSEMONT, Illinois — On Sunday, May 21, leaders in the eye care field gathered here for the first live...
May 3, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE A gold mine for cutting-edge myopia research, the ARVO Meeting, held...
April 17, 2023 By Ashley Wallace-Tucker, OD, FAAO, FSLS Subjective: A 12-year-old African American male presented to our clinic for his first...
April 17, 2023 By Carolyn Lederman, MD I’ve found that it’s been helpful when talking to parents about myopia management to tell...
March 15, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Researchers from Taiwan analyzed the changes in visual function when progressive...
March 15, 2023 By Brianna Rhue, OD, FAAO, FSLS We need better involvement from all health care professionals to reach as many...
March 15, 2023 By Matthew J. Martin, OD, FIAOMC Subjective A 12-year-old female Asian patient “WG” was referred to our office by...
March 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Low concentration (0.01% to 0.05%) atropine effectively slows myopia progression in...
March 1, 2023 By Kate A. McClure, OD, MS, FAAO Parents who are skeptical of myopia management therapies often lack understanding and...
March 1, 2023 By Peter (Zhi) Chen, MD, PhD, Fudan University Eye and ENT Hospital, Shanghai, China Low-concentration atropine is needed only...
March 1, 2023 By Vittorio Mena OD, MS Subjective Two children, accompanied by their parents, presented at my clinic for comprehensive eye...
February 15, 2023 NASHVILLE, Tenn. — U.S. pharmaceutical company Harrow has released its compounded, patent-pending formulas of low-dose atropine. Eye care professionals...
February 15, 2023 By Jagrut Lallu, BOptom, MSc In 2009, most optometrists and ophthalmologists were not open to myopia management despite growing...
February 1, 2023 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Among the interventions currently available to manage childhood myopia, low-concentration atropine,...